2020-03-04
Novavax, Inc., a clinical-stage biotechnology company that produces innovative vaccines to prevent a broad spectrum of infectious diseases with the slogan of “creating tomorrow's vaccines today,” has lately initiated the development of a vaccine candidate for the novel coronavirus relying on its proprietary recombinant nanoparticle vaccine technology and the genetic sequence of this newly...
